Table of Contents Author Guidelines Submit a Manuscript
Corrigendum

A corrigendum for this article has been published. To view the corrigendum, please click here.

Evidence-Based Complementary and Alternative Medicine
Volume 2012, Article ID 161235, 12 pages
http://dx.doi.org/10.1155/2012/161235
Research Article

Ferulic Acid, an Angelica sinensis-Derived Polyphenol, Slows the Progression of Membranous Nephropathy in a Mouse Model

1Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, No. 250 Wu-Hsing Street, Xinyi District, Taipei City 110, Taiwan
2School of Pharmacy, National Defense Medical Center, No. 161, Section 6, Minquan E. Road, Neihu District, Taipei City 114, Taiwan
3Division of Nephrology, Department of Internal Medicine, Tri-Service General Hospital, No. 325, Section 2, Chenggong Road, Neihu District, Taipei City 114, Taiwan
4Department of Internal Medicine, Shuang Ho Hospital, Taipei Medical University, No. 291, Zhongzheng Road, Zhonghe District, New Taipei City 235, Taiwan

Received 12 March 2012; Revised 14 May 2012; Accepted 14 May 2012

Academic Editor: Jairo Kenupp Bastos

Copyright © 2012 Chao-Wen Cheng et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. B. G. Oliveira, “Membranous nephropathy: an IgG4-mediated disease,” The Lancet, vol. 351, no. 9103, pp. 670–671, 1998. View at Publisher · View at Google Scholar · View at Scopus
  2. F. H. Ferraz, C. G. Martins, J. C. Cavalcanti et al., “Profile of glomerular diseases in a public hospital of Federal District, Brazil,” Jornal Brasileiro de Nefrologia, vol. 32, no. 3, pp. 249–256, 2010. View at Google Scholar · View at Scopus
  3. S. G. Massry and R. J. Glassock, Massry & Glassock's Textbook of Nephrology, Williams & Wilkins, Baltimore, Md, USA, 1995.
  4. D. Kerjaschki and T. J. Neale, “Molecular mechanisms of glomerular injury in rat experimental membranous nephropathy (Heymann nephritis),” Journal of the American Society of Nephrology, vol. 7, no. 12, pp. 2518–2526, 1996. View at Google Scholar · View at Scopus
  5. L. H. Beck Jr., R. G. B. Bonegio, G. Lambeau et al., “M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy,” The New England Journal of Medicine, vol. 361, no. 1, pp. 11–21, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. C. C. Wu, J. S. Chen, S. H. Lin, A. Chen, H. K. Sytwu, and Y. F. Lin, “Experimental model of membranous nephropathy in mice: sequence of histological and biochemical events,” Laboratory Animals, vol. 42, no. 3, pp. 350–359, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. J. S. Chen, J. C. Hwang, L. C. Chang, C. C. Wu, and Y. F. Lin, “Attributes of antiangiogenic factor plasminogen kringle 5 in glomerulonephritis,” Archives of Pathology and Laboratory Medicine, vol. 134, no. 12, pp. 1804–1812, 2010. View at Google Scholar · View at Scopus
  8. H. Debiec, F. Lefeu, M. J. Kemper et al., “Early-childhood membranous nephropathy due to cationic bovine serum albumin,” The New England Journal of Medicine, vol. 364, no. 22, pp. 2101–2110, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. S. V. Shah, “Oxidants and iron in progressive kidney disease,” Journal of Renal Nutrition, vol. 16, no. 3, pp. 185–189, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. C. C. Wu, K. C. Lu, J. S. Chen et al., “HO-1 induction ameliorates experimental murine membranous nephropathy: anti-oxidative, anti-apoptotic and immunomodulatory effects,” Nephrology Dialysis Transplantation, vol. 23, no. 10, pp. 3082–3090, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. Y. Maeshima and H. Makino, “Angiogenesis and chronic kidney disease,” Fibrogenesis Tissue Repair, vol. 3, article 13, 2010. View at Google Scholar
  12. K. Miyamoto, Y. Kitamoto, H. Tokunaga et al., “Protective effect of vascular endothelial growth factor/vascular permeability factor 165 and 121 on glomerular endothelial cell injury in the rat,” Laboratory Investigation, vol. 84, no. 9, pp. 1126–1136, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. E. M. Thompson, J. Hughes, S. Van Noorden, J. Sharpe, and J. Savill, “Expression of the multifunctional extracellular matrix protein thrombospondin in crescentic glomerulonephritis,” Journal of Pathology, vol. 178, no. 1, pp. 89–94, 1996. View at Publisher · View at Google Scholar · View at Scopus
  14. B. F. Schrijvers, A. Flyvbjerg, and A. S. De Vriese, “The role of vascular endothelial growth factor (VEGF) in renal pathophysiology,” Kidney International, vol. 65, no. 6, pp. 2003–2017, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. Y. L. Cheng, W. L. Chang, S. C. Lee et al., “Acetone extract of Angelica sinensis inhibits proliferation of human cancer cells via inducing cell cycle arrest and apoptosis,” Life Sciences, vol. 75, no. 13, pp. 1579–1594, 2004. View at Publisher · View at Google Scholar · View at Scopus
  16. L. Yi, Y. Liang, H. Wu, and D. Yuan, “The analysis of Radix Angelicae Sinensis (Danggui),” Journal of Chromatography A, vol. 1216, no. 11, pp. 1991–2001, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. K. J. Zhao, T. T. X. Dong, P. F. Tu, Z. H. Song, C. K. Lo, and K. W. K. Tsim, “Molecular genetic and chemical assessment of radix Angelica (Danggui) in China,” Journal of Agricultural and Food Chemistry, vol. 51, no. 9, pp. 2576–2583, 2003. View at Publisher · View at Google Scholar · View at Scopus
  18. H. W. Lam, H. C. Lin, S. C. Lao et al., “The angiogenic effects of Angelica sinensis extract on HUVEC in vitro and zebrafish in vivo,” Journal of Cellular Biochemistry, vol. 103, no. 1, pp. 195–211, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. S. J. Wu, L. T. Ng, and C. C. Lin, “Antioxidant activities of some common ingredients of traditional chinese medicine, Angelica sinensis, Lycium barbarum and Poria cocos,” Phytotherapy Research, vol. 18, no. 12, pp. 1008–1012, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. K. Wojcikowski, H. Wohlmuth, D. W. Johnson, M. Rolfe, and G. Gobe, “An in vitro investigation of herbs traditionally used for kidney and urinary system disorders: potential therapeutic and toxic effects,” Nephrology, vol. 14, no. 1, pp. 70–79, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. Y. C. Po, Y. L. Hoi, A. H. Y. Siu et al., “Dang-Gui Buxue Tang protects against oxidant injury by enhancing cellular glutathione in H9c2 cells: role of glutathione synthesis and regeneration,” Planta Medica, vol. 73, no. 2, pp. 134–141, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. C. Wilasrusmee, J. Siddiqui, D. Bruch, S. Wilasrusmee, S. Kittur, and D. S. Kittur, “In vitro immunomodulatory effects of herbal products,” American Surgeon, vol. 68, no. 10, pp. 860–864, 2002. View at Google Scholar · View at Scopus
  23. Y. You, K. Kim, H. G. Yoon et al., “Chronic effect of ferulic acid from Pseudosasa japonica leaves on enhancing exercise activity in mice,” Phytotherapy Research, vol. 24, no. 10, pp. 1508–1513, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. V. Witko-Sarsat, V. Gausson, A. T. Nguyen et al., “AOPP-induced activation of human neutrophil and monocyte oxidative metabolism: a potential target for N-acetylcysteine treatment in dialysis patients,” Kidney International, vol. 64, no. 1, pp. 82–91, 2003. View at Publisher · View at Google Scholar · View at Scopus
  25. A. M. Jentzsch, H. Bachmann, P. Fürst, and H. K. Biesalski, “Improved analysis of malondialdehyde in human body fluids,” Free Radical Biology and Medicine, vol. 20, no. 2, pp. 251–256, 1996. View at Publisher · View at Google Scholar · View at Scopus
  26. J. S. Chen, A. Chen, L. C. Chang et al., “Mouse model of membranous nephropathy induced by cationic bovine serum albumin: antigen dose-response relations and strain differences,” Nephrology Dialysis Transplantation, vol. 19, no. 11, pp. 2721–2728, 2004. View at Publisher · View at Google Scholar · View at Scopus
  27. Z. H. Song, Z. N. Ji, C. K. Lo et al., “Chemical and biological assessment of a traditional Chinese herbal decoction prepared from radix astragali and radix angelicae sinensis: orthogonal array design to optimize the extraction of chemical constituents,” Planta Medica, vol. 70, no. 12, pp. 1222–1227, 2004. View at Publisher · View at Google Scholar · View at Scopus
  28. M. Srinivasan, R. Rukkumani, A. R. Sudheer, and V. P. Menon, “Ferulic acid, a natural protector against carbon tetrachloride-induced toxicity,” Fundamental and Clinical Pharmacology, vol. 19, no. 4, pp. 491–496, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. M. Srinivasan, A. R. Sudheer, and V. P. Menon, “Ferulic acid: therapeutic potential through its antioxidant property,” Journal of Clinical Biochemistry and Nutrition, vol. 40, no. 2, pp. 92–100, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. M. Ohnishi, T. Matuo, T. Tsuno et al., “Antioxidant activity and hypoglycemic effect of ferulic acid in STZ-induced diabetic mice and KK-Ay mice,” BioFactors, vol. 21, no. 1–4, pp. 315–319, 2004. View at Google Scholar · View at Scopus
  31. R. J. Johnson, W. G. Couser, and E. Y. Chi, “New mechanism for glomerular injury. Myeloperoxidase-hydrogen peroxide-halide system,” Journal of Clinical Investigation, vol. 79, no. 5, pp. 1379–1387, 1987. View at Google Scholar · View at Scopus
  32. G. Schrijver, J. Schalkwijk, J. C. M. Robben, K. J. M. Assmann, and R. A. P. Koene, “Antiglomerular basement membrane nephritis in beige mice. Deficiency of leukocytic neutral proteinases prevents the induction of albuminuria in the heterologous phase,” Journal of Experimental Medicine, vol. 169, no. 4, pp. 1435–1448, 1989. View at Google Scholar · View at Scopus
  33. M. Kobayashi, H. Sugiyama, D. H. Wang et al., “Catalase deficiency renders remnant kidneys more susceptible to oxidant tissue injury and renal fibrosis in mice,” Kidney International, vol. 68, no. 3, pp. 1018–1031, 2005. View at Publisher · View at Google Scholar · View at Scopus
  34. P. Duann, P. K. Datta, C. Pan, J. B. Blumberg, M. Sharma, and E. A. Lianos, “Superoxide dismutase mimetic preserves the glomerular capillary permeability barrier to protein,” Journal of Pharmacology and Experimental Therapeutics, vol. 316, no. 3, pp. 1249–1254, 2006. View at Publisher · View at Google Scholar · View at Scopus
  35. D. H. Kang, S. Anderson, Y. G. Kim et al., “Impaired angiogenesis in the aging kidney: vascular endothelial growth factor and thrombospondin-1 in renal disease,” American Journal of Kidney Diseases, vol. 37, no. 3, pp. 601–611, 2001. View at Google Scholar · View at Scopus
  36. D. H. Kang, A. H. Joly, S. W. Oh et al., “Impaired angiogenesis in the remnant kidney model: I. Potential role of vascular endothelial growth factor and thrombospondin-1,” Journal of the American Society of Nephrology, vol. 12, no. 7, pp. 1434–1447, 2001. View at Google Scholar · View at Scopus
  37. Y. Masuda, A. Shimizu, T. Mori et al., “Vascular endothelial growth factor enhances glomerular capillary repair and accelerates resolution of experimentally induced glomerulonephritis,” American Journal of Pathology, vol. 159, no. 2, pp. 599–608, 2001. View at Google Scholar · View at Scopus
  38. V. Eremina, M. Sood, J. Haigh et al., “Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases,” Journal of Clinical Investigation, vol. 111, no. 5, pp. 707–716, 2003. View at Publisher · View at Google Scholar · View at Scopus
  39. V. Eremina, H. J. Baelde, and S. E. Quaggin, “Role of the VEGF-A signaling pathway in the glomerulus: evidence for crosstalk between components of the glomerular filtration barrier,” Nephron, vol. 106, no. 2, pp. p32–p37, 2007. View at Publisher · View at Google Scholar · View at Scopus
  40. J. Wang, Z. Yuan, H. Zhao et al., “Ferulic acid promotes endothelial cells proliferation through up-regulating cyclin D1 and VEGF,” Journal of Ethnopharmacology, vol. 137, no. 2, pp. 992–997, 2011. View at Publisher · View at Google Scholar · View at Scopus
  41. C. M. Lin, J. H. Chiu, I. H. Wu, B. W. Wang, C. M. Pan, and Y. H. Chen, “Ferulic acid augments angiogenesis via VEGF, PDGF and HIF-1α,” Journal of Nutritional Biochemistry, vol. 21, no. 7, pp. 627–633, 2010. View at Publisher · View at Google Scholar · View at Scopus
  42. W. R. Ji, L. G. Barrientos, M. Llinás et al., “Selective inhibition by kringle 5 of human plasminogen on endothelial cell migration, an important process in angiogenesis,” Biochemical and Biophysical Research Communications, vol. 247, no. 2, pp. 414–419, 1998. View at Publisher · View at Google Scholar · View at Scopus
  43. P. G. Tipping and A. R. Kitching, “Glomerulonephritis, Th1 and Th2: what's new?” Clinical and Experimental Immunology, vol. 142, no. 2, pp. 207–215, 2005. View at Publisher · View at Google Scholar · View at Scopus
  44. H. R. Kim, D. M. Lee, S. H. Lee et al., “Chlorogenic acid suppresses pulmonary eosinophilia, IgE production, and Th2-type cytokine production in an ovalbumin-induced allergic asthma: activation of STAT-6 and JNK is inhibited by chlorogenic acid,” International Immunopharmacology, vol. 10, no. 10, pp. 1242–1248, 2010. View at Publisher · View at Google Scholar · View at Scopus
  45. C. Iwamura, K. Shinoda, M. Yoshimura, Y. Watanabe, A. Obata, and T. Nakayama, “Naringenin chalcone suppresses allergic asthma by inhibiting the type-2 function of CD4 T cells,” Allergology International, vol. 59, no. 1, pp. 67–73, 2010. View at Publisher · View at Google Scholar · View at Scopus
  46. W. K. Jung, I. Choi, S. Oh et al., “Anti-asthmatic effect of marine red alga (Laurencia undulata) polyphenolic extracts in a murine model of asthma,” Food and Chemical Toxicology, vol. 47, no. 2, pp. 293–297, 2009. View at Publisher · View at Google Scholar · View at Scopus
  47. G. Ahn, I. Hwang, E. Park et al., “Immunomodulatory effects of an enzymatic extract from Ecklonia cava on murine splenocytes,” Marine Biotechnology, vol. 10, no. 3, pp. 278–289, 2008. View at Publisher · View at Google Scholar · View at Scopus
  48. J. Gong, F. T. Liu, and S. S. Chen, “Polyphenolic antioxidants enhance IgE production,” Immunological Investigations, vol. 33, no. 3, pp. 295–307, 2004. View at Publisher · View at Google Scholar · View at Scopus
  49. M. S. Islam, T. Murata, M. Fujisawa et al., “Anti-inflammatory effects of phytosteryl ferulates in colitis induced by dextran sulphate sodium in mice,” British Journal of Pharmacology, vol. 154, no. 4, pp. 812–824, 2008. View at Publisher · View at Google Scholar · View at Scopus
  50. X. L. Wang, X. H. Hu, M. E. Lü, Z. L. Gu, and C. G. Ruan, “Effects of ferulic acid on E-selectin expression in activated endothelial cell and leukocyte-endothelial cell adhesion,” Yaoxue Xuebao, vol. 40, no. 5, pp. 410–413, 2005. View at Google Scholar · View at Scopus
  51. R. J. Glassock, “The pathogenesis of idiopathic membranous nephropathy: a 50-year odyssey,” American Journal of Kidney Diseases, vol. 56, no. 1, pp. 157–167, 2010. View at Publisher · View at Google Scholar · View at Scopus